S Bank Fund Management Ltd lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 38.8% in the third quarter, Holdings Channel.com reports. The fund owned 14,077 shares of the healthcare conglomerate’s stock after purchasing an additional 3,933 shares during the period. S Bank Fund Management Ltd’s holdings in UnitedHealth Group were worth $4,861,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of UNH. LFA Lugano Financial Advisors SA purchased a new stake in UnitedHealth Group in the second quarter worth about $25,000. Sagard Holdings Management Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $29,000. Islay Capital Management LLC purchased a new stake in UnitedHealth Group in the second quarter worth $31,000. Riggs Asset Managment Co. Inc. lifted its position in UnitedHealth Group by 69.4% during the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 43 shares during the period. Finally, Kilter Group LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $34,000. Institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
Several research firms recently commented on UNH. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a research note on Wednesday, October 29th. KeyCorp boosted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Bank of America upped their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Barclays lifted their target price on shares of UnitedHealth Group from $386.00 to $391.00 and gave the stock an “overweight” rating in a report on Monday, January 5th. Finally, Evercore ISI upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $385.75.
UnitedHealth Group Stock Down 1.0%
UNH opened at $340.64 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a 50 day moving average price of $329.65 and a 200-day moving average price of $321.60. The stock has a market capitalization of $308.57 billion, a price-to-earnings ratio of 17.78, a PEG ratio of 2.08 and a beta of 0.42.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.15 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is 46.14%.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealth released two independent Milliman studies saying Medicare Advantage cost the federal government less and reduces beneficiary out‑of‑pocket costs — a direct defense aimed at countering the Senate findings. New Independent Studies: Medicare Advantage Delivers Greater Value
- Positive Sentiment: Analyst/sector commentary highlights a broader healthcare rebound (including UNH exposure) tied to GLP‑1 adoption and sector re‑rating, which could support demand for the stock over the medium term. This ETF Is Proof That the Healthcare Rebound Is Real (UNH)
- Neutral Sentiment: Post‑Q3 buy/hold/sell pieces and market commentators are re‑examining UNH’s valuation and growth outlook; these provide analytical context but no new company catalysts. UnitedHealth (UNH): Buy, sell, or hold post Q3 earnings?
- Neutral Sentiment: Market TV / video shows (Final Trades) list UNH among stocks to watch — useful for sentiment tracking but not an immediate fundamental driver. Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
- Negative Sentiment: A Senate committee report (summarized by Reuters/WSJ) says UnitedHealth used aggressive tactics to collect diagnosis codes that can inflate Medicare Advantage payments — the catalyst cited for today’s stock weakness and the main regulatory risk investors are pricing in. Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
- Negative Sentiment: Coverage notes the stock has already reacted (slipping on the headlines) and raises the chance of follow‑on probes or enforcement; investors should watch any regulatory statements, CMS guidance, or litigation risk updates. UnitedHealth stock falls after Senate report finds aggressive Medicare tactics
- Negative Sentiment: Separate reporting flags renewed scrutiny of UnitedHealth’s nursing‑home practices, adding another regulatory/reputational overhang that could prolong volatility. UnitedHealth used aggressive Medicare tactics, Senate committee report says
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
